ACTU Q1 2026 Earnings EPS Misses Estimates as Biotech Firm Continues RD Investment Lucid Diagnostics Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Firm Advances Commercial Rollout PALI Q1 2026 Earnings EPS Misses Estimates as Palisade Bio Advances Pipeline Efforts ODFL Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Operational Performance Chemed Corp Q1 2026 Earnings EPS Surpasses Estimates as Operational Efficiency Drives Performance ROP Q1 2026 Earnings EPS Surpasses Estimates by 258 Amid Market Headwinds